BALA CYNWYD, Pa., April 24, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Pacific Premier Bancorp, Inc. (Nasdaq - PPBI)
Under the terms of the agreement, Pacific Premier will be acquired by Columbia Banking System, Inc. (“Columbia”) (Nasdaq - COLB). Pacific Premier stockholders will receive 0.9150 of a share of Columbia common stock for each Pacific Premier share they own. The merger is valued at approximately $2.0 billion, or $20.83 per Pacific Premier share, based on Columbia’s closing stock price of $22.77 on April 22, 2025. Following closing, Pacific Premier stockholders will own approximately 30% of Columbia's outstanding shares of common stock. The investigation concerns whether the Pacific Premier Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares. For example, the deal consideration is below the 52-week high of $30.28 for the Company’s shares.
Additional information can be found at https://www.brodskysmith.com/cases/pacific-premier-bancorp-inc-nasdaq-ppbi/.
Southern States Bancshares, Inc. (Nasdaq - SSBK)
Under the terms of the Merger Agreement, Southern States will be acquired by FB Financial Corporation. Southern States shareholders will receive 0.800 shares of FB Financial common stock for each share of Southern States stock. Based on FB Financial’s closing stock price of $47.05 per share as of March 28, 2025, the implied transaction value is approximately $37.64 per Southern States share, or $381 million, in the aggregate. The investigation concerns whether the Southern States Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.
Additional information can be found at https://www.brodskysmith.com/cases/southern-states-bancshares-inc-nasdaq-ssbk/.
Akoya Biosciences, Inc. (Nasdaq - AKYA)
Under the terms of the agreement, Akoya will be acquired by Quanterix Corporation (Nasdaq - QTRX). Akoya Biosciences shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Following the close of the transaction, Quanterix shareholders will own approximately 70% of the combined company and Akoya shareholders will own approximately 30%, on a fully diluted basis. The investigation concerns whether the Akoya Biosciences Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.
Additional information can be found at https://www.brodskysmith.com/cases/akoya-biosciences-inc-nasdaq-akya/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
